328 related articles for article (PubMed ID: 26467267)
1. Fatal posterior revesible leukoencephalopathy syndrome associated coma induced by bevacizumab in metastatic colorectal cancer and review of literature.
Eryılmaz MK; Mutlu H; Salim DK; Musri FY; Coşkun HŞ
J Oncol Pharm Pract; 2016 Dec; 22(6):806-810. PubMed ID: 26467267
[TBL] [Abstract][Full Text] [Related]
2. Posterior Reversible Encephalopathy Syndrome (PRES) Presenting as Status Epilepticus: A Case Report and Literature Review.
Sharma P; Abbas MK; Huynh M
Conn Med; 2016 Sep; 80(8):475-478. PubMed ID: 29782783
[TBL] [Abstract][Full Text] [Related]
3. [Posterior Reversible Encephalopathy Syndrome (PRES): About 4 cases].
Chanal E; Bouleftour W; Rivoirard R; Bosaki C; Forges F; Jacquin JP; Fournel P; Mery B; Saban-Roche L
Presse Med; 2019 Oct; 48(10):1026-1031. PubMed ID: 31653541
[No Abstract] [Full Text] [Related]
4. Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer.
Wang W; Zhao LR; Lin XQ; Feng F
World J Gastroenterol; 2014 Jun; 20(21):6691-7. PubMed ID: 24914397
[TBL] [Abstract][Full Text] [Related]
5. Posterior reversible encephalopathy syndrome (PRES) with sub-arachnoid haemorrhage after bevacizumab and 5-FU.
Massey J
J Clin Neurosci; 2017 Jun; 40():57-59. PubMed ID: 28238523
[TBL] [Abstract][Full Text] [Related]
6. Fatal outcome of posterior "reversible" encephalopathy syndrome in metastatic colorectal carcinoma after irinotecan and fluoropyrimidine chemotherapy regimen.
Dedić Plavetić N; Rakušić Z; Ozretić D; Simetić L; Krpan AM; Bišof V
World J Surg Oncol; 2014 Aug; 12():264. PubMed ID: 25142792
[TBL] [Abstract][Full Text] [Related]
7. Nonconvulsive status epilepticus related to posterior reversible leukoencephalopathy syndrome induced by cetuximab.
Palma JA; Gomez-Ibañez A; Martin B; Urrestarazu E; Gil-Bazo I; Pastor MA
Neurologist; 2011 Sep; 17(5):273-5. PubMed ID: 21881470
[TBL] [Abstract][Full Text] [Related]
8. Long-term consequences of the posterior reversible encephalopathy syndrome in eclampsia and preeclampsia: a review of the obstetric and nonobstetric literature.
Postma IR; Slager S; Kremer HP; de Groot JC; Zeeman GG
Obstet Gynecol Surv; 2014 May; 69(5):287-300. PubMed ID: 25101694
[TBL] [Abstract][Full Text] [Related]
9. Posterior reversible encephalopathy syndrome: a case study.
Wright KL; Polito MH; French AE
Am J Nurs; 2012 May; 112(5):36-40; quiz 41-2. PubMed ID: 22546734
[TBL] [Abstract][Full Text] [Related]
10. Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature.
Deguchi S; Mitsuya K; Nakasu Y; Hayashi N; Katagiri H; Murata H; Wasa J; Takahashi M; Endo M
Invest New Drugs; 2018 Apr; 36(2):346-349. PubMed ID: 29067537
[TBL] [Abstract][Full Text] [Related]
11. Posterior reversible encephalopathy syndrome after bevacizumab treatment presenting to the ED as chest pain and headache.
Miller AH; Monteiro de Oliveira Novaes JA; Brock PA; Sandoval M
Am J Emerg Med; 2016 Sep; 34(9):1916.e1-2. PubMed ID: 26947375
[No Abstract] [Full Text] [Related]
12. Reversible posterior leukoencephalopathy syndrome caused by bevacizumab: report of a case.
Koopman M; Muller EW; Punt CJ
Dis Colon Rectum; 2008 Sep; 51(9):1425-6. PubMed ID: 18470563
[No Abstract] [Full Text] [Related]
13. Adverse effects of bevacizumab in metastatic colorectal cancer : a case report and literature review.
Willems E; Gerne L; George C; D'Hondt M
Acta Gastroenterol Belg; 2019; 82(2):322-325. PubMed ID: 31314196
[TBL] [Abstract][Full Text] [Related]
14. PRES and RCVS: Two Distinct Entities or a Spectrum of the Same Disease?
Jeanneret V; Jillella DV; Rangaraju S; Groover O; Peterson R; Koneru S; Nahab F; Kase CS
J Stroke Cerebrovasc Dis; 2022 Jun; 31(6):106472. PubMed ID: 35390732
[TBL] [Abstract][Full Text] [Related]
15. Posterior Reversible Encephalopathy Syndrome in Patients With Cancer.
Singer S; Grommes C; Reiner AS; Rosenblum MK; DeAngelis LM
Oncologist; 2015 Jul; 20(7):806-11. PubMed ID: 26032137
[TBL] [Abstract][Full Text] [Related]
16. Posterior reversible encephalopathy syndrome in a pregnant patient without eclampsia or preeclampsia.
Acar H; Acar K
Am J Emerg Med; 2018 Sep; 36(9):1721.e3-1721.e4. PubMed ID: 29880411
[TBL] [Abstract][Full Text] [Related]
17. Posterior Reversible Encephalopathy Syndrome Associated with Sorafenib and Successful Retreatment.
Laruelle M; Filleul B; Duprez T; Machiels JP
Urol Int; 2018; 100(3):357-360. PubMed ID: 26845702
[TBL] [Abstract][Full Text] [Related]
18. Posterior reversible encephalopathy syndrome (PRES): a rare condition after resection of posterior fossa tumors: two new cases and review of the literature.
González Quarante LH; Mena-Bernal JH; Martín BP; Ramírez Carrasco M; Muñoz Casado MJ; Martínez de Aragón A; de las Heras RS
Childs Nerv Syst; 2016 May; 32(5):857-63. PubMed ID: 26584552
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and outcomes of posterior reversible encephalopathy syndrome following bevacizumab treatment.
Seet RC; Rabinstein AA
QJM; 2012 Jan; 105(1):69-75. PubMed ID: 21865314
[TBL] [Abstract][Full Text] [Related]
20. Pazopanib induced unilateral posterior reversible encephalopathy syndrome.
Arslan BM; Bajrami A; Demir E; Cabalar M; Yayla V
Ideggyogy Sz; 2017 Mar; 70(3-4):140-144. PubMed ID: 29870619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
